Changes in the immune status of patients with metastatic solid tumors during stereotactic radiation therapy: dependence on dose and amount of irradiated metastasis
pdf (Русский)

Keywords

metastatic tumor process
stereotactic body radiation therapy (SBRT)
total focal dose (TFD)
ammount of irradiated metastases
immune status
activation of T-lymphocytes

How to Cite

Zozulia, A., Baldueva, I., Novikov , S. ., Girdiuk, D., Emelianova, N., Tyuryaeva, E. ., Fedosova, E., Antipov, F. ., Arsenev, A., Korobova , I. . ., Girshovich, M. ., Kanaev, S., & Belyaev, A. (2021). Changes in the immune status of patients with metastatic solid tumors during stereotactic radiation therapy: dependence on dose and amount of irradiated metastasis. Voprosy Onkologii, 67(3), 391–396. https://doi.org/10.37469/0507-3758-2021-67-3-391-396

Abstract

Purpose. To evaluate immunological status in patients with metastatic forms of solid tumors before and at different intervals after stereotactic body radiation therapy (SBRT) of metastatic lesions depending on the dose and the number of irradiated metastasis.

Materials and methods. A quantitative assessment and analysis of blood immunological parameters was conducted before irradiation, via 3-4 weeks and via 6-8 weeks after SBRT in patients with malignant tumors with oligometastases in the liver and lungs, in groups with a total focal dose (TFD ≤ 45 Gy ) and TFD> 45 Gy, and also in groups with irradiation of one metastases and two or more. All peripheral blood samples were analyzed by flow cytometry. Statistical analysis was performed using Friedman and Nemenyi criteria.

Results. 3-4 weeks after the end of SBRT, when using higher doses (TFD> 45 Gy), we observed statistically significant increase of T-lymphocytes (CD3+CD19-); T-helpers (CD3+CD4+); activated T-helpers (CD3+CD4+HLA-DR+); activated cytotoxic T-lymphocytes (CD3+СD8+HLA-DR+). Decreasing of B-lymphocytes (CD3+CD19-) was observed in both dose groups (TFD ≤ 45 Gy and TFD > 45 Gy). We also noted the activation of the T-cell link of immunity both in the group with irradiation of one metastatic lesion, and in the group where 2 or more metastases were exposed to irradiation.

Conclusion. Using of higher doses of SBRT is associated with a more activated antitumor T-cell immune response, while the analysis of groups of patients with different ammount of irradiated metastasis currently requires further research.

https://doi.org/10.37469/0507-3758-2021-67-3-391-396
pdf (Русский)

References

Xing D, Siva S, Hanna GG. The abscopal effect of stereotactic radiotherapy and immunotherapy: fool’s gold or el dorado? Clin Oncol (R Coll Radiol). 2019;31(7):432–443. https://doi.org/10.1016/j.clon.2019.04.006.

Ngwa W, Irabor OC, Schoenfeld JD et al. Using immunotherapy to boost the abscopal effect. Nat Rev Cancer 2018;18(5):313–322. https://doi.org/10.1038/nrc.2018.6.

Зозуля А.Ю., Новиков С.Н., Балдуева И.А. и др. Изменение иммунного статуса у пациентов с метастатическими формами солидных опухолей на фоне стереотаксической лучевой терапии // Вопросы онкологии. 2020;66(3):277–282.

Friedman, Milton (March 1940). "A comparison of alternative tests of significance for the problem of m rankings". The Annals of Mathematical Statistics. 11(1):86–92.

Nemenyi P. (1963) Distribution-free Multiple Comparisons. Ph.D. thesis, Princeton University.

Golden EB, Frances D, Pellicciotta I. et al. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology. 2014;3:e28518. https://doi.org/10.4161/onci.28518.

Gerber SA, Sedlacek AL, Cron KR, et al. IFN-gamma mediates the antitumor effects of radiation therapy in a murine colon tumor. Am J Pathol 2013; 182:2345–2354. https://doi.org/10.1016/j.ajpath.2013.02.041.

Зозуля А.Ю., Балдуева И.А., Новиков С.Н. Иммунологические эффекты стереотаксической лучевой терапии при злокачественных новообразованиях различных локализаций: обзор литературы // Сибирский онкологический журнал. 2020;19(5):108–113.

Marconi R, Strolin S, Bossi G, Strigari L. A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger? PLoS ONE 2017;12(2):1–16. https://doi.org/10.1371/journal.pone.0171559.

Brooks ED, Chang JY. Time to abandon single-site irradiation for inducing abscopal effects. Nat Rev Clin Oncol., 2019;16:123e–135.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2021